GlycoMimetics Inc (NASDAQ:GLYC) shares traded 2.18% higher at $0.29 on Wall Street last session.
GLYC stock price is now 10.31% away from the 50-day moving average and 2.94% away from the 200-day moving average. The market capitalization of the company currently stands at $18.71M.
On December 22, 2023, CapitalOne recently initiated its ‘Overweight’ rating on the stock quoting a target price of $12, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Invus Public Equities, L.P., 10% Owner sold 260,873 shares of the company’s stock on Aug 08 ’24. The stock was sold for $50,009 at an average price of $0.19. Upon completion of the transaction, the 10% Owner now directly owns 6,317,565 shares in the company, valued at $1.83 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 07 ’24, 10% Owner Invus Public Equities, L.P. sold 61,488 shares of the business’s stock. A total of $11,197 was realized by selling the stock at an average price of $0.18. This leaves the insider owning 6,578,438 shares of the company worth $1.91 million. A total of 11.50% of the company’s stock is owned by insiders.
During the past 12 months, GlycoMimetics Inc has had a low of $0.14 and a high of $3.36. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 1.92, and a quick ratio of 1.92. The fifty day moving average price for GLYC is $0.263 and a two-hundred day moving average price translates $0.2819 for the stock.
The latest earnings results from GlycoMimetics Inc (NASDAQ: GLYC) was released for 2024-12-31.
